Viewing Study NCT06732505


Ignite Creation Date: 2025-12-25 @ 3:10 AM
Ignite Modification Date: 2025-12-31 @ 1:20 PM
Study NCT ID: NCT06732505
Status: RECRUITING
Last Update Posted: 2025-06-26
First Post: 2024-12-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Study to Assess the Safety and Efficacy of [225Ac]Ac-DOTATATE in Patients With SSTR+ GEP-Nens
Sponsor: Peking University Cancer Hospital & Institute
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-09-29
Start Date Type: ACTUAL
Primary Completion Date: 2025-12-31
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-03-31
Completion Date Type: ESTIMATED
First Submit Date: 2024-12-10
First Submit QC Date: None
Study First Post Date: 2024-12-13
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-06-22
Last Update Post Date: 2025-06-26
Last Update Post Date Type: ACTUAL